| 000 | 01100 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518071608.0 | ||
| 264 | 0 | _c20210427 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.1080/10428194.2019.1691191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHernández-Marqués, Carmen | |
| 245 | 0 | 0 |
_aCan monitoring asparaginase activity help us to manage toxicity in pediatric acute lymphoblastic leukemia? _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _c04 2020 |
||
| 300 |
_a990-992 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aAsparaginase _xmetabolism |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdiagnosis |
| 700 | 1 | _aAndión, Maitane | |
| 700 | 1 | _aPerez-Somarriba, Marta | |
| 700 | 1 | _aMadero, Luis | |
| 700 | 1 | _aLassaletta, Alvaro | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 61 _gno. 4 _gp. 990-992 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428194.2019.1691191 _zAvailable from publisher's website |
| 999 |
_c30334587 _d30334587 |
||